Navigation Links
Orthokine Treatment is Effective for Knee Arthritis, Even After Two Years
Date:8/5/2008

Long-Term Clinical Study Confirms Effectiveness of Autologous Therapy

DUSSELDORF, Germany, August 5 /PRNewswire/ -- The results of a two-year representative study of knee osteoarthritis, published in the internationally renowned journal "Osteoarthritis and Cartilage", confirm the safety and effectiveness of Orthokine therapy, in which anti-inflammatory proteins obtained from the patient's own blood are injected into the arthritic joint.

Researchers at Heinrich Heine University in Dusseldorf compared three treatments to determine which one produces the best long-term results for treatment of knee osteoarthritis. A total of 310 patients received a series of injections one of Orthokine, hyaluronic acid (a joint lubricant), or a placebo (table salt solution). Because of the chronic nature of arthritis, long-term treatment effects are particularly important for sufferers.

Two years after the initial treatment, 188 of the 310 patients were still experiencing reduced pain and improved function of the affected joint. The Orthokine group had the fewest patients who went on to seek further treatment. Patients who received Orthokine treatment had the greatest improvements in VAS and WOMAC scores. For the WOMAC test in particular, the outcomes were as follows: Starting from an initial WOMAC score of 124, the Orthokine group saw a reduction to a score of 58, while the final WOMAC scores for the other two groups remained well above that at 88 and 84. "This study shows that Orthokine treatment is a safe alternative to conventional methods", says study physician Carsten Moser.

"Osteoarthritis and Cartilage" is a respected scientific journal (impact factor 4.017) that publishes only original, peer-reviewed research into new methods for the treatment of diseases of the locomotor system.

Further information:

Orthogen AG

Frau Daniele Voss

Graf-Adolf-Str. 41

40210 Dusseldorf

Tel.: +49(0)211-60-255-35

Fa
'/>"/>

SOURCE Orthogen AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
3. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...dsandJOHANNESBURG,November25/PRNewswire/--,iThemba...nouncedtoday,thattheyhavesignedacollaborativeagree... Pyxis,sworldclasscomputationalchemistryandleaddis...ivisiontoprovidemedicinaland,syntheticchemistrysup...lclientnetwork.iThembaPharmaceuticalsandPyxisDisco...
(Date:11/25/2009)....,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,announce...ROTECT-1(theProspectiveRandomizedOralTherapyEvalua...-B)inpatientswithmoderate-to-severeCrohn,sdiseased...tolerabilityprofile.Thestudydemonstratedevidenceof...efinedasa70-pointdecreaseintheCrohn,sDiseaseActivi...
(Date:11/24/2009)...PRNewswire/-- ,, WHAT:RomHoubens,aBelgianmantho...ent,wasactuallyfullyconsciousandawakeduringthattim...ynaVoxEyeMaxwasfeaturedinthesegmenttoillustratehow...lockcommunication. ,, WHEN:GoodMorningAmerica--...oxtech.com ,, WHO:RomHoubenswasanengineerin...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Emdeon Acquires eRx Network LLC 50665 1Emdeon Acquires eRx Network LLC 50665 2Emdeon Acquires eRx Network LLC 50665 3New Drug Could Work Against Leukemia 50663 1Sexist jokes favor the mental mechanisms that justify violence against women 50661 1Sexist jokes favor the mental mechanisms that justify violence against women 50661 2
...cals, a division of Wyeth (NYSE: WYE ), announced...(FDA) has issued an approvable letter for,the firs... the treatment of,adult patients with community-ac..., the FDA requested that Wyeth provide,additional ...ACIL for the,treatment of patients with CAP with i...
...val Benefit in Complete and Partial Respo...HEIGHTS, N.J., May 29 Genta,Incorporated (OTC Bul...erm,followup from a Phase 3 trial of the Company,s...dium) Injection, in patients with chronic,lymphocy...data show that,patients who achieved either a comp...
Other Medicine Technology:Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 2Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 3Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 4Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 5Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 6Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 2Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 3Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 4
(Date:11/25/2009)...nimally-invasive procedures that provide patients ...k of sinusitis, or sinus infection, are being deve...oring Institute. Techniques such as balloon sinup...having to remove any bone or tissue like tradition...throughs in treating sinus symptoms were featured ...
(Date:11/25/2009)...wire/--Therearemanywaysyoucanimprove,yourhealth,an...waysseemstobeconflictingadviceconcerningwhatisgood...o,therealbuzz.comteamhascompiledalistof25health-bo...tible!Doingacombinationof,oursuggestedactivitieswi...eing-sotrythemout. , 1.Reduceyourfatintake.Th...
(Date:11/24/2009)...ercent of radiation oncologists use advanced imagi... (FDG-PET), magnetic resonance imaging (MRI), and ...t delineation (to locate the tumor and other areas...le in the December issue of the Journal of the Am...rg ). , In defining the target, the radiation on...
(Date:11/24/2009)...of Miami School of Medicine compared the outcomes ...nts for nonalcoholic steatohepatitis (NASH) versus...stically significant differences in post-transplan... Study findings are presented in the December issu...by Wiley-Blackwell on behalf of the American Assoc...
(Date:11/24/2009)...ton University School of Medicine (BUSM) and the B... have identified a number of proteins whose activa... normal cells with almost 97 percent accuracy. In ...computational strategy to analyze this data and sp...ular circuits) that are active in cancer and "dorm...
Breaking Medicine News(10 mins):Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 2Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 3Health News:Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain 4Health News:realbuzz.com - Top 25 Ways to Improve Your Health & get a Better Sex Life! 2Health News:New data emerges on liver transplant survival rates 2Health News:New data emerges on liver transplant survival rates 3Health News:Researchers identify proteins in lung cancer cells that may provide potential drug targets 2
...covered that suffering from infection increases th...hich is a dangerous condition in which blood clots... That infection can cause an increase in the risk ... that infection can also cause DVT. Research...
...h HIV/AIDS have opposed a patent application filed...ir, a fixed dose combination AIDS drug on the grou... // Represented by the Lawyers' Collective ...tion to a patent application filed at the Kolkata ...
...ical Center and John Hopkins University School of ...aling pathway that plays a vital role in the embry...o injury lead to the development of liver cancer. ...rgeted treatment of liver cancer, which happens to...
... propagate a new method of sex education for young...vice president with the China Family Planning Asso... arrived earlier in recent years, but sex educatio...ar. Education on sex and reproductive health ...
... among city kids in Britain, increasing their susc...archers, only 37% of the urban kids really walk to...suburban areas. Nearly 47% of the kids spend almos...he above 40 age group. In Britain, more than ...
...ggests, that a pain killing medication helps by ha... common form of breast cancer. The name of the pai...iments on breast cancer cells, scientists found th...e most common breast cancer in postmenopausal wome...
Other Medicine News:Health News:HIV Patients Opposes Patenting Of AIDS Drug 2Health News:Unchecked Cellular Repair Pathway Causes Liver Cancer 2Health News:Pain-killer Drug Can Help Fight Breast Cancer 2
O.R. Special Procedure Apron
Special Procedure Apron
Easy Wrap Apron
Disposable Monopolar NeedleElectrodes With Detachable Lead Wire
Medicine Products: